§ 312.1. Scope.
101 words·~1 min read·
/us/cfr/t21/s§ 312.1·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)This part contains procedures and requirements governing the use of investigational new drugs, including procedures and requirements for the submission to, and review by, the Food and Drug Administration of investigational new drug applications (IND's). An investigational new drug for which an IND is in effect in accordance with this part is exempt from the premarketing approval requirements that are otherwise applicable and may be shipped lawfully for the purpose of conducting clinical investigations of that drug.
(b)References in this part to regulations in the Code of Federal Regulations are to chapter I of title 21, unless otherwise noted.
Connections20 cite this
Cited by 20 sections
register
- NoticesNotice
- NoticesNotice
- NoticesNotice
- NoticesNotice
- NoticesNotice
- NoticesNotice
- NoticesNotice
- Rules and RegulationsNotice
- NoticesDEPARTMENT OF HEALTH AND HUMAN SERVICES
- NoticesNotice
- NoticesNotice
- NoticesNotice
- NoticesNotice
- NoticesNotice
- NoticesNotice
- Proposed RulesNotice
- NoticesNotice
- NoticesNotice
- NoticesNotice
Citation graph
cites case law
§ 312.1
Scope.
Fed. Reg.×19
C.F.R.×1
Cites 0Cited by 20 across 2 sources